IDYA
NASDAQ
US
IDEAYA Biosciences, Inc. - Common Stock
$32,74
▲ +$0,26
(+0,80%)
Vol. 694K
3
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$3.0B
ROE
-15,5%
Margine
-5,2%
D/E
0,00
Beta
0,09
52W
$13–$37
Consenso Wall Street
25 analisti · Apr 20269
Acquisto forte
13
Compra
3
Mantieni
0
Vendi
0
Vendita forte
88,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
TWST
Twist Bioscience Corp
$1.9B
CPRX
Catalyst Pharmaceuticals Inc
P/E 13,2
$2.9B
ARQT
Arcutis Biotherapeutics Inc
$3.6B
VERA
Vera Therapeutics, Inc
$3.5B
TVTX
Travere Therapeutics Inc
$3.4B
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110,3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
IRON
Disc Medicine Inc
$3.0B
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $-0,99 | $-0,94 | +$0,05 |
| Set 2025 | $-0,56 | $1,33 | +$1,89 |
| Giu 2025 | $-0,81 | $-0,88 | $-0,08 |
| Mar 2025 | $-0,67 | $-0,82 | $-0,15 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $7.0M | — | — | $207.8M | $10.9M |
| Utile netto | -$130.3M | -$71.4M | -$77.5M | $119.2M | -$83.3M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -31.4% | -31.4% | -31.4% | -31.4% | -15.5% | -15.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -1861.6% | -1861.6% | -1861.6% | -5.2% | -5.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 12.39 | 12.39 | 12.39 | 12.39 | 12.44 | 12.44 |
Rapporti chiave
ROA (TTM)
-14,4%
P/S (TTM)
14,11
P/B
2,1
EPS (TTM)
$-1,85
CF/Share
$-1,89
Crescita ricavi 3A
-37,0%
52W High
$37,08
52W Low
$13,45
$13,45
Intervallo 52 settimane
$37,08
Salute finanziaria
Flusso di cassa libero
-$90.8M
Debito netto
-$84.9M
Liquidità
$112.8M
Debito totale
$27.9M
Aggiornato al Dic 31, 2025
Як IDYA виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка IDYA vs аналоги Biotechnology
P/E
—
▼
0%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
14,1
▲
10%
sopra
peer
(12,9)
vs Peer
vs Settore
Valore equo
P/B
2,1
▼
15%
sotto
peer
(2,5)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість IDYA vs аналоги Biotechnology
ROE
-15,5%
▲
77%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Top livello
Net margin
-5,2%
▲
98%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
—
▼
0%
sotto
peer
(78,6%)
vs Peer
vs Settore
In linea
ROA
-14,4%
▲
69%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя IDYA vs аналоги Biotechnology
D/E ratio
0,0
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
12,4
▲
180%
sopra
peer
(4,4)
vs Peer
vs Settore
Liquidità forte
Beta
0,1
▼
91%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів IDYA
IDYA
Mediana peer
Industria
IDYA прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
IDYA vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
STEIN JEFFREY
Director · Mar 02
50000 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 44,23%FMR, LLC
14,97%
$409.5M
Blackrock Inc.
9,35%
$255.6M
Janus Henderson Group PLC
8,18%
$223.8M
Capital Research Global Inv…
6,01%
$164.4M
Vanguard Group Inc
5,72%
$156.3M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora